Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1– Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|11|7|570-575

ISSN： 1570-162X

Source： Current HIV Research, Vol.11, Iss.7, 2013-10, pp. : 570-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recreational substance use and tolerance of efavirenz in HIV-1 infected patients

By Faggian F.   Lattuada E.   Lanzafame M.   Antolini D.   Concia E.   Vento S.  

AIDS Care, Vol. 17, Iss. 7, 2005-10 ,pp. : 908-910

Routledge Ltd

Access to resources Recommend Favorite

Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine

By  

Current HIV Research, Vol. 7, Iss. 5, 2009-09 ,pp. : 526-532

Bentham Science Publishers

Access to resources Recommend Favorite

Haemostatic Activation in HIV Infected Patients Treated with Different Antiretroviral Regimens

By  

Current HIV Research, Vol. 6, Iss. 1, 2008-01 ,pp. : 70-76

Bentham Science Publishers

Access to resources Recommend Favorite

Neurosyphilis in HIV-infected patients

By Philip Susan S   Klausner Jeffrey D  

Future HIV Therapy, Vol. 2, Iss. 6, 2008-11 ,pp. : 595-602

Future Medicine

Access to resources Recommend Favorite

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

By  

Current HIV Research, Vol. 14, Iss. 1, 2016-01 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite